<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01608152</url>
  </required_header>
  <id_info>
    <org_study_id>2012-0362</org_study_id>
    <secondary_id>NCI-2020-00573</secondary_id>
    <secondary_id>2012-0362</secondary_id>
    <secondary_id>P30CA016672</secondary_id>
    <secondary_id>R41CA168107</secondary_id>
    <nct_id>NCT01608152</nct_id>
  </id_info>
  <brief_title>Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors</brief_title>
  <official_title>Using Game Mechanics to Improve Outcomes Among Stem Cell Transplant Survivors</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>M.D. Anderson Cancer Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Cancer Institute (NCI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>M.D. Anderson Cancer Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This trial collects feedback from patients to develop a video game in improving the outcomes
      in stem cell transplant survivors. A video game may help to improve health behaviors for
      leukemia or lymphoma patients after stem cell transplant.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      PRIMARY OBJECTIVES:

      I. Develop a prototype intervention electronic game that implements a baseline testable
      feature set, including features for social networking within a virtual game space, managing
      an intermittent mediated reward cycle, goal setting and tracking, and collaborative problem
      solving.

      II. Evaluate the technical merit, feasibility, user perception and acceptance of the
      prototype system with adolescents and young adults (AYAs) allogeneic hematopoietic stem cell
      transplantation (HSCTs) patients in recovery.

      OUTLINE: Patients are assigned to 1 of 2 groups.

      GROUP I: Patients attend a focus group for up to 1.5 hours and provide feedback on design
      elements, specific desirable features, and preferences for the initial prototype.

      GROUP II: Patients have access to the game for 3 weeks and then provide feedback on problems
      or questions regarding the use of the prototype.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">February 20, 2013</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Feasibility of electronic game intervention</measure>
    <time_frame>4 weeks</time_frame>
    <description>Primary feasibility benchmark based on responses to questions regarding users' perceptions of the technology. If 75% of respondents have a mean score reflecting positive responses (e.g., strongly agree or agree) to each of the 7 constructs related to users' perceptions, as described above, then feasibility benchmark met. Responses to open-ended questions analyzed qualitatively using Atlas.ti software. Responses to individual questions evaluated to look for common themes, and findings used to inform future development of the prototype.</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">40</enrollment>
  <condition>Leukemia</condition>
  <condition>Lymphoma</condition>
  <arm_group>
    <arm_group_label>Group I (focus group)</arm_group_label>
    <description>Patients attend a focus group for up to 1.5 hours and provide feedback on design elements, specific desirable features, and preferences for the initial prototype.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group II (access to the game)</arm_group_label>
    <description>Patients have access to the game for 3 weeks and then provide feedback on problems or questions regarding the use of the prototype.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Focus Group</intervention_name>
    <description>Attend a focus group</description>
    <arm_group_label>Group I (focus group)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Internet-Based Intervention</intervention_name>
    <description>Have access to the game</description>
    <arm_group_label>Group II (access to the game)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Interview</intervention_name>
    <description>1 week after the 3-week period ends, interview conducted over the phone or at a clinic visit.</description>
    <arm_group_label>Group II (access to the game)</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with leukemia or lymphoma
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        1) Age 15-29 years

          -  Diagnosis of leukemia or lymphoma

          -  Able to speak, read and write English

          -  First time allogeneic stem cell transplant recipient

        Exclusion Criteria:

          -  Unable to participate in the study due to language, vision, cognitive or other
             difficulties, as advised by their health care provider(s)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>29 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Susan K Peterson</last_name>
    <role>Principal Investigator</role>
    <affiliation>M.D. Anderson Cancer Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>M D Anderson Cancer Center</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.mdanderson.org</url>
    <description>University of Texas MD Anderson Cancer Center Website</description>
  </link>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>May 25, 2012</study_first_submitted>
  <study_first_submitted_qc>May 29, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 30, 2012</study_first_posted>
  <last_update_submitted>March 6, 2020</last_update_submitted>
  <last_update_submitted_qc>March 6, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 10, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Leukemia</keyword>
  <keyword>Lymphoma</keyword>
  <keyword>Game mechanics</keyword>
  <keyword>Stem cell transplant survivors</keyword>
  <keyword>Hematopoietic stem cell transplantation</keyword>
  <keyword>HSCT</keyword>
  <keyword>Internet-based</keyword>
  <keyword>Interactive and personalized intervention</keyword>
  <keyword>Questionnaires</keyword>
  <keyword>Focus groups</keyword>
  <keyword>Interviews</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Leukemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

